DIAPRIDE M4 FORTE (Glimepiride (4mg) + Metformin (1000mg))

Diapride M4 Forte Tablet is classified as an anti-diabetic medication and is prescribed for the management of type 2 diabetes mellitus in adult patients. This medication combines two different therapeutic agents that work together to help regulate blood glucose levels effectively. For optimal results, it is recommended to take Diapride M4 Forte with meals, and it should be ingested consistently at the same time each day. The prescribing physician will determine the appropriate dosage based on individual response and blood sugar monitoring, which may require adjustments over time. It is crucial for patients to continue using this medication even if they feel well or their blood sugar appears stable, as discontinuation without medical advice can lead to elevated blood glucose levels, increasing the risk of serious complications such as kidney damage, vision loss, neuropathy, and amputation. Additionally, patients should incorporate a balanced diet, regular physical activity, and weight management into their treatment plan, as these lifestyle factors significantly impact diabetes management. A common adverse effect associated with Diapride M4 Forte is hypoglycemia, characterized by symptoms such as sweating, dizziness, headaches, and tremors; hence, patients should be aware of these signs and know how to address them. Regular meals and a quick source of glucose, like sugary snacks or juice, should be kept handy to prevent low blood sugar episodes. Furthermore, consuming alcohol may heighten the risk of hypoglycemia and should be avoided. Other potential side effects include alterations in taste, nausea, diarrhea, abdominal discomfort, headaches, and respiratory infections. Some individuals may also experience weight gain while on this medication. It is important to note that Diapride M4 Forte is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment. Patients are advised to disclose any history of heart disease to their healthcare provider, as this may influence treatment decisions. Regular monitoring of blood glucose levels and health assessments are vital during therapy.